سعر ملسا11.5% كريم لتأخير نمو الشعر 30جم 2022

Malsa eflornithine 11.5% cream 30 g, topical hair-growth retardant for facial hirsutism in women (Debeiky / IGEA Pharma, Egypt).

• Treatment of facial hirsutism in womenPopulation: Adult womenEuropean Medicines Agency (EPAR product information)

• Mostly mild skin reactions: acne (very common); pseudofolliculitis barbae, alopecia, burning/stinging/tingling skin, dry skin, pruritus, erythema, irritated skin, rash and folliculitis (common).International label, equivalent formulation · European Medicines Agency (EPAR product information)

• Hypersensitivity to eflornithine or to any of the excipients.International label, equivalent formulation · European Medicines Agency (EPAR product information)

• Excessive hair growth can result from serious underlying disorders (e.g. polycystic ovary syndrome, androgen-secreting neoplasm) or medicines (e.g. ciclosporin, glucocorticoids, minoxidil, phenobarbital, phenytoin, combined oestrogen-androgen HRT); consider these before prescribing.International label, equivalent formulation · European Medicines Agency (EPAR product information)
• For cutaneous use only; avoid contact with eyes and mucous membranes; transient stinging or burning may occur on abraded or broken skin; if irritation develops reduce to once daily, and stop and consult a doctor if it persists. Contains cetostearyl and stearyl alcohol (local skin reactions) and parabens (possible delayed allergic reactions) in the EU product.International label, equivalent formulation · European Medicines Agency (EPAR product information)

• Limited pregnancy data (22 exposed pregnancies) show no clinical evidence of harm, but animal studies showed reproductive toxicity and the human risk is unknown; women who are pregnant or planning pregnancy should use an alternative means to manage facial hair.International label, equivalent formulation · European Medicines Agency (EPAR product information)
• It is not known whether eflornithine or its metabolites are excreted in human milk; women should not use it while breastfeeding.International label, equivalent formulation · European Medicines Agency (EPAR product information)

• Eflornithine: Irreversibly inhibits ornithine decarboxylase, an enzyme involved in production of the hair shaft by the hair follicle, reducing the rate of hair growth (EU SmPC).